Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma. - Wikidata - awgldk - TriplyDB

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

http://www.wikidata.org/entity/Q35164197

about

Studying Cellular Signal Transduction with OMIC Technologies Trial Watch-Immunostimulation with cytokines in cancer therapy A trans-acting Variant within the Transcription Factor RIM101 Interacts with Genetic Background to Determine its Regulatory Capacity.Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma Adaptive Resistance to an Inhibitor of Chromosomal Instability in Human Cancer Cells.Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas.Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors

P2860

Q24289429-0CA779BB-2E2A-4979-808A-73F21485E782 Q28078725-49F33026-5FA5-4A70-A8B0-FD4973BA06F8 Q35890257-41F0956C-FF19-4741-A390-7C309894B28E Q36257430-0120333D-8C5A-4DEC-8BC1-2DCD0F773E3D Q37458376-91BFE27C-47DA-4561-98BD-3BCEB14DA44F Q39933783-3888A854-FD8B-4008-AC04-A6CDD9629F13 Q40969918-EE56C57F-FFDC-4059-8B55-E304F103D98B

P2860

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

http://www.wikidata.org/entity/Q35164197

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@ast

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@en

type

label

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@ast

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@en

prefLabel

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@ast

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@en

P1433

Q35164197-CA7A4CA4-D9D2-476B-AA79-9DDFB2FEC9B0

P1476

Q35164197-196852F7-DB0E-4DAC-8774-7322A6F02334

P2093

Q35164197-24E67B05-63C1-42A5-A177-F52A32BACEC7

Q35164197-3D7BFAC3-2F86-4DAB-90C2-6E2FB9787BB5

Q35164197-4E320734-D77B-4A3F-A59A-B313DA993A94

Q35164197-62323BCC-257C-4AD3-8FA3-2A80FDB851C7

Q35164197-629B594B-4577-4FF2-96BA-72E9703913BD

Q35164197-6B180897-8150-449D-9778-A1105EA956FB

Q35164197-8512E1B8-8CEF-464A-B09B-4B1B7D53A7B7

Q35164197-8E0FF809-4003-45BA-8351-76BFFE04FA91

Q35164197-A8AD5A7D-A218-417B-A4F0-2975F0971983

Q35164197-AC942E33-403D-42D6-AF76-0013EA56F705

P2860

Q35164197-003DDC80-643E-4467-AC1A-42FCD172928D

Q35164197-006A77CB-5C93-41E8-B62F-B8CE938C9559

Q35164197-0921F609-2E82-472A-9BC8-BD4D613A6825

Q35164197-187A16C0-AD4F-4048-9C34-3EBF4FA2E9E4

Q35164197-19C6A7DB-E831-4461-A145-0A15118364C5

Q35164197-2AA4DD0A-1107-430E-BFF0-6B736C44C978

Q35164197-3B815BDB-0799-4671-B40D-287805AEE4F6

Q35164197-3E1564CD-26EF-4913-BC03-2B5FAC12F6B6

Q35164197-48559A63-3993-4B44-A256-381D309A3E18

Q35164197-4C7D7B18-BE5B-4B99-A33E-A974EBC95D4E

P304

Q35164197-3D3E8D96-E179-4A2C-9CE1-0183EA6EE674

P31

Q35164197-8C0404B7-CDF7-4ADE-9244-74AF13FDD2FC

P356

Q35164197-510F777A-4D0F-48F4-8B66-AC53041334E9

P433

Q35164197-36BA9535-9878-4B32-B570-DE1B688DBF95

P478

Q35164197-7F31A5C0-3093-416C-93FF-425F085A7C84

P50

Q35164197-F6037F0A-1D77-43C1-8E98-7FFB3CA0FB3D

P577

Q35164197-AEBB8A3A-58BB-48A9-9AA9-29D22F15889E

P5875

Q35164197-B29DB5B0-1431-4660-9052-2F585C54B0FB

P698

Q35164197-88238632-4141-4137-96B0-FD5A6C8F9A6A

P921

Q35164197-FA86F835-3BA6-4B8B-8AB7-C2F6AB498703

P932

Q35164197-4F5020FF-0055-403A-9D97-911D6CDDE616

P356

J.MOLCEL.2014.12.030

P1433

P1476

Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

@en

P2093

Bo-Juen Chen

http://www.w3.org/2001/XMLSchema#string

Christine Pratilas

http://www.w3.org/2001/XMLSchema#string

Dana Pe'er

http://www.w3.org/2001/XMLSchema#string

Mark Rocco

http://www.w3.org/2001/XMLSchema#string

Noel Goddard

http://www.w3.org/2001/XMLSchema#string

Nul Loren Oh

http://www.w3.org/2001/XMLSchema#string

Oren Litvin

http://www.w3.org/2001/XMLSchema#string

Sarit Schwartz

http://www.w3.org/2001/XMLSchema#string

Tanya Schild

http://www.w3.org/2001/XMLSchema#string

Zhenmao Wan

http://www.w3.org/2001/XMLSchema#string

P2860

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

A landscape of driver mutations in melanoma

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

Statistical significance for genomewide studies

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Mechanisms of type-I- and type-II-interferon-mediated signalling

P304

784-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLCEL.2014.12.030

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274832847

http://www.w3.org/2001/XMLSchema#string

P698

25684207

http://www.w3.org/2001/XMLSchema#string

P921

P932

4355234

http://www.w3.org/2001/XMLSchema#string